NanoCellect Biomedical Reinvents the Cell Sorter with the WOLF G2
Expanded capabilities for a broader set of scientific applications
News provided by
Share this article
Share this article
SAN DIEGO, May 13, 2021 /PRNewswire/ NanoCellect Biomedical, a leader in the development of cell sorting, announces the virtual launch, scheduled for May 18, 2021, of the WOLF G2 Cell Sorter, the newest addition to NanoCellect s family of products. The WOLF G2 features simple and sterile cell sorting. This versatile system is ideally suited for use in cutting-edge research in academic and biopharma laboratories involved in single-cell genomics, gene editing, cell line development, immunology, infectious diseases, and general cell enrichment.
Operator
Good morning, and welcome to the Icahn Enterprises L.P. Q1 2021 earnings call with Jesse Lynn, general counsel; Keith Cozza, president and CEO; and SungHwan Cho, chief financial officer. I would now like to hand the call over to Jesse Lynn, who will read the opening statement.
Jesse Lynn
General Counsel
Thank you, operator. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements we make in this presentation, including statements regarding our future performance and plans for our businesses and potential acquisitions. Forward-looking statements may be identified by words such as expects, anticipates, intends, plans, believes, seeks, estimates, will, or words of similar meaning and include, but are not limited to statements about the expected future business and financial performance of Icahn Enterprises L.P. and its subsidiaries.
The U.S. conglomerate will name its new finance chief at a later date.
Icahn Enterprises LP lost close to 20% in the stock market last year.
Activist investor Carl Icahn said on Sunday that Icahn Enterprises LP (NASDAQ: IEP) will name Aris Kekedjian as its new CEO. Kekedjian had the role of Chief Investment Officer at the U.S. conglomerate until 2019 and has also served at General Electric in the past as a co-executive.
Icahn Enterprises is currently trading at a per-share price of £39.66. In comparison, the stock had started the year at £37.56 per share after recovering from a low of £30.26 per share in March 2020, when the impact of the ongoing COVID-19 crisis was at its peak. If you want to invest in the stock market online, you will need a reliable stockbroker – here is a comparison of the top few to make selection easier for you.
By Reuters Staff
2 Min Read
FILE PHOTO: Billionaire activist-investor Carl Icahn gives an interview on FOX Business Network s Neil Cavuto show in New York February 11, 2014. REUTERS/Brendan McDermid
(Reuters) -Billionaire activist investor Carl Icahn’s investment firm on Monday named General Electric Co veteran and a former dealmaker, Aris Kekedjian, as its president and chief executive officer.
Kekedjian, who has worked with GE for about three decades until 2019, will replace Icahn Enterprises LP’s CEO Keith Cozza. Cozza, leaving on May 31, joined Icahn’s investment vehicle in 2004 and took over as the CEO in 2014.
Chief Financial Officer SungHwan Cho will also be departing, Icahn Enterprises said, adding it was currently searching for a successor.